Author(s): Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh

Email(s): onlyharsh24@gmail.com

DOI: Not Available

Address: Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh
Assistant Professor, M.M College of Nursing, Mullana Ambala, Haryana
*Corresponding Author

Published In:   Volume - 7,      Issue - 10,     Year - 2014


ABSTRACT:
Combination antiviral therapy helps to prevent the virus that causes hepatitis C from reproducing in the body along with HIV. Peg interferon and Ribavirin are combined to give the best response to treatment in case of HIV Positive. A protease inhibitor (such as Boceprevir or telaprevir) also may be given along with peg interferon and Ribavirin. Combination antiviral therapy is prescribed for those who have ongoing (chronic) hepatitis C infection. This therapy has certain side-effects that comes with medicine. Usually the benefits of the medicine are more important than any minor side effects i. e Fatigue, headache, muscle and joint aches etc. Periodic liver function tests and a liver biopsy every 3 to 5 years come in the special considerations. Follow-up care is a key part of treatment and safety. One has to be sure to make and go to all appointments, and call the doctor if there is any problem.


Cite this article:
Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh. Triple Combination Antiviral Therapy. Research J. Pharm. and Tech. 7(10): Oct. 2014 Page 1190-1192.

Cite(Electronic):
Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh. Triple Combination Antiviral Therapy. Research J. Pharm. and Tech. 7(10): Oct. 2014 Page 1190-1192.   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2014-7-10-10


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available